Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Mayo Clinic Proceedings
|
October 7, 2024
Unusual Osteoclast-like Plasma Cells in a Case of IgA Lambda Light Chain-Restricted Myeloma
Rosalie M Sterner, Jennifer L Herrick
Frontiers in Oncology
|
October 4, 2024
EGFRVIII and EGFR targeted chimeric antigen receptor T cell therapy in glioblastoma
Robert C Sterner, Rosalie M Sterner
Current Opinion in Hematology
|
November 26, 2019
Myeloid cell and cytokine interactions with chimeric antigen receptor-T-cell therapy: implication for future therapies
Rosalie M Sterner, Saad S Kenderian
Frontiers in Immunology
|
January 23, 2023
Immune response following traumatic spinal cord injury: Pathophysiology and therapies
Robert C Sterner, Rosalie M Sterner
Frontiers in Immunology
|
September 9, 2022
Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy
Robert C Sterner, Rosalie M Sterner
Blood Cancer Journal
|
April 7, 2021
CAR-T cell therapy: current limitations and potential strategies
Robert C Sterner, Rosalie M Sterner
Journal of Clinical & Cellular Immunology
|
August 19, 2014
The Pathogenesis of Lupus Nephritis
Rosalie M Sterner, Stella P Hartono, Joseph P Grande
Journal of the American Medical Directors Association
|
July 28, 2016
Active Vaccines for Alzheimer Disease Treatment
Rosalie M Sterner, Paul Y Takahashi, Aimee C Yu Ballard
Journal of Visualized Experiments : Jove
|
August 6, 2019
Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
Rosalie M Sterner, Michelle J Cox, Reona Sakemura, et al.
Clinical Chemistry
|
August 1, 2025
An Ambiguous NUDT15 Signal in a Child with B-cell Acute Lymphoblastic Leukemia
Rosalie M Sterner, Farha Sherani, Margaret A DiGuardo, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Mayo Clinic Proceedings
|
October 7, 2024
Unusual Osteoclast-like Plasma Cells in a Case of IgA Lambda Light Chain-Restricted Myeloma
Rosalie M Sterner, Jennifer L Herrick
Frontiers in Oncology
|
October 4, 2024
EGFRVIII and EGFR targeted chimeric antigen receptor T cell therapy in glioblastoma
Robert C Sterner, Rosalie M Sterner
Current Opinion in Hematology
|
November 26, 2019
Myeloid cell and cytokine interactions with chimeric antigen receptor-T-cell therapy: implication for future therapies
Rosalie M Sterner, Saad S Kenderian
Frontiers in Immunology
|
January 23, 2023
Immune response following traumatic spinal cord injury: Pathophysiology and therapies
Robert C Sterner, Rosalie M Sterner
Frontiers in Immunology
|
September 9, 2022
Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy
Robert C Sterner, Rosalie M Sterner
Blood Cancer Journal
|
April 7, 2021
CAR-T cell therapy: current limitations and potential strategies
Robert C Sterner, Rosalie M Sterner
Journal of Clinical & Cellular Immunology
|
August 19, 2014
The Pathogenesis of Lupus Nephritis
Rosalie M Sterner, Stella P Hartono, Joseph P Grande
Journal of the American Medical Directors Association
|
July 28, 2016
Active Vaccines for Alzheimer Disease Treatment
Rosalie M Sterner, Paul Y Takahashi, Aimee C Yu Ballard
Journal of Visualized Experiments : Jove
|
August 6, 2019
Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
Rosalie M Sterner, Michelle J Cox, Reona Sakemura, et al.
Clinical Chemistry
|
August 1, 2025
An Ambiguous NUDT15 Signal in a Child with B-cell Acute Lymphoblastic Leukemia
Rosalie M Sterner, Farha Sherani, Margaret A DiGuardo, et al.
Page
of 3